COVID-19, social distancing measures, and the need for efficient use of healthcare resources have resulted in a significant rise in the use of telemedicine. Recent changes to the regulatory and reimbursement rules for telemedicine have further contributed to this rise.
How has the legislative and regulatory environment changed recently in response to COVID-19 with respect to telemedicine? What federal income tax issues apply to both taxable and tax-exempt healthcare providers who employ telemedicine? When the use of telemedicine crosses state lines, what are the state and local tax consequences?
Please join professionals from KPMG’s Washington National Tax Practice, State and Local Tax Practice, and the Center for Healthcare Regulatory Insight as they delve deeper into these regulatory and tax considerations.